Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2015-04-16FDA Approved: ESCITALOPRAM — Supplemental Application (Accord Healthcare Inc.)
The FDA approved Accord Healthcare's supplemental application for a generic escitalopram product.
-
FDA approval · 2015-04-13FDA Approved: NORTRIPTYLINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved Teva's supplemental application for Nortriptyline hydrochloride (generic) under anANDA, updating the approval of this produ…
-
FDA approval · 2015-03-27FDA Approved: EMSAM — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for EMSAM (selegiline) by Viatris Specialty LLC.
-
FDA approval · 2015-03-16FDA Approved: VIIBRYD — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for VIIBRYD (vilazodone hydrochloride) from Allergan, Inc.
-
FDA approval · 2015-03-16FDA Approved: FLUOXETINE — Original Application (Vensun Pharmaceuticals, Inc.)
The FDA approved Vensun Pharmaceuticals' original (ANDA) application for fluoxetine hydrochloride, establishing a generic fluoxetine product…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2015-01-16FDA Approved: MIRTAZAPINE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for the generic antidepressant mirtazapine from Aurobindo Pharma Limited.
-
FDA approval · 2015-01-16FDA Approved: MIRTAZAPINE — Supplemental Application (Aurolife Pharma LLC)
FDA approved a supplemental application for Mirtazapine from Aurolife Pharma LLC (ANDA 076921). The action reflects a regulatory approval re…
-
FDA approval · 2015-01-12FDA Approved: FLUOXETINE — Supplemental Application (Chartwell Governmental & Specialty RX, LLC)
FDA approved a supplemental application for a generic fluoxetine product (ANDA 076458) from Chartwell Governmental & Specialty RX, LLC. This…
-
FDA approval · 2015-01-05FDA Approved: DESIPRAMINE HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for desipramine hydrochloride (Actavis Pharma, Inc.), updating the labeling for the product unde…
-
FDA approval · 2015-01-05FDA Approved: DESIPRAMINE HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved Actavis Pharma, Inc.'s supplemental application for desipramine hydrochloride (a generic antidepressant).
-
FDA approval · 2015-01-05FDA Approved: DESIPRAMINE HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for desipramine hydrochloride (Actavis Pharma, Inc.).
-
FDA approval · 2014-12-30FDA Approved: WELLBUTRIN XL — Supplemental Application (Bausch Health US LLC)
FDA approved a supplemental application for WELLBUTRIN XL (bupropion hydrochloride) from Bausch Health US LLC.
-
FDA approval · 2014-12-20FDA Approved: BUPROPION HYDROCHLORIDE XL — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for Bupropion Hydrochloride XL from Actavis Pharma, Inc., formalizing approval of an extended-releas…
-
FDA approval · 2014-12-19FDA Approved: OLANZAPINE AND FLUOXETINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva's supplemental application for a generic olanzapine and fluoxetine fixed-dose product, expanding access to the olanzapine/…
-
FDA approval · 2014-12-19FDA Approved: OLANZAPINE AND FLUOXETINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approves Teva's supplemental application for a generic fixed-dose combination of olanzapine and fluoxetine (olanzapine and fluoxetine).
-
FDA approval · 2014-12-18FDA Approved: BUPROPION HYDROCHLORIDE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical Industries, Inc.'s original application for a generic bupropion hydrochloride product. The approval covers i…
-
FDA approval · 2014-12-17FDA Approved: EFFEXOR XR — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for Effexor XR (venlafaxine hydrochloride) by Viatris Specialty LLC. The action is to modify labelin…
-
FDA approval · 2014-12-13FDA Approved: PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for a generic Perphenazine and Amitriptyline Hydrochloride product manufactured by Mylan Pharmac…
-
FDA approval · 2014-12-13FDA Approved: ESCITALOPRAM — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for escitalopram (ESCITSLOPRAM), a generic antidepressant, bringing a generic v…
-
FDA approval · 2014-12-10FDA Approved: ESCITALOPRAM OXALATE — Supplemental Application (Amneal Pharmaceuticals LLC)
The FDA approved a supplemental application for Escitalopram Oxalate from Amneal Pharmaceuticals LLC, enabling a generic version of escitalo…
-
FDA approval · 2014-12-10FDA Approved: CITALOPRAM — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for the generic antidepressant citalopram from Torrent Pharmaceuticals Limited.
-
FDA approval · 2014-12-01FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental application for bupropion hydrochloride from Amneal Pharmaceuticals of New York LLC, confirming a regulatory act…
-
FDA approval · 2014-12-01FDA Approved: PAROXETINE — Supplemental Application (Padagis US LLC)
FDA approved a supplemental application for paroxetine submitted by Padagis US LLC, adding or updating labeling under the existing NDA.
-
FDA approval · 2014-11-26FDA Approved: PAROXETINE — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for PAROXETINE (paroxetine hydrochloride) from Zydus Lifesciences Limited, enabling the marketing of…
-
FDA approval · 2014-11-20FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for bupropion hydrochloride from Sun Pharmaceutical Industries, indicating an approved addition or m…